NIH seeks histopathology and antibody screening for progeria mouse model samples.
The National Institutes of Health (NIH) intends to procure histopathology and antibody screening services for preclinical trial samples from a Hutchinson Gilford progeria syndrome mouse model undergoing DNA editing therapy. The work involves processing and analyzing tissue samples to evaluate therapeutic efficacy. The contractor must have experience with histopathology, antibody screening, and mouse model studies. The place of performance is Bethesda, Maryland. This is a presolicitation notice; no value is indicated.